In addition, overexpression of miR-33a was observed in clinical glioma specimens and cell lines, which negatively regulated the expression of SIRT6 via targeting the 3’UTR mRNA, thereby decreasing ROS production and increasing Bcl-2 expression to inhibit apoptosis [101]. This evidence concerns the gene SIRT6 and central nervous system cancer.